Editorial · 29 Dec 2025
Conference abstractPublished 14 Jun 2019
rHDL: A versatile drug/biologic delivery platform
University of North Texas Health Science Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lipoprotein-based technologies could address many of the concerns of traditional chemotherapy via their ability to selectively deliver their payload to cancer cells and tumors via a receptor-mediated mechanism. Moreover, they have been shown to be equally effective for targeted diagnostic imaging. Specifically, it has been shown that malignant cells consistently overexpress Scavenger receptor class B type 1 (SR-B1) receptors compared to normal cells which are the receptor for lipoprotein based nanoparticles. The therapeutic index of many cytotoxic drugs can thus be significantly improved by enhancing the selective delivery and accumulation of the therapeutic agent in malignant cells and tumors vs. healthy cells and tissue, thus avoiding toxic side effects. Lipoprotein-based nanoparticles have the potential to perform tumor selective delivery and thus overcome these limitations. We will present some of our recent findings and progress in the area of lipoprotein drug delivery. Consequently, reconstituted (synthetic) lipoproteins have proven to be a superior biocompatible drug-delivery platform and thus have great potential for cancer theranostics.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 29 Jun 2025
Hydrogels: Versatile Platforms in Drug Delivery and Tissue Engineering
Article · 20 Jun 2025
Liposomes: Versatile Nano carriers Revolutionizing Drug Delivery
Commentary · 31 Mar 2023
Liposomes: A Versatile Drug Delivery System
Editorial · 2012
Pulmonary Drug Delivery Systems, A Versatile Technique
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sangram Raut”
